Facebook
Twitter
LinkedIn
Forward2024 Department of Medicine Grand Rounds | An Overview of Autoimmune and Paraproteinemia Related Neuropathies
Neuropathy is one of the most common complications seen in patients with cancer diagnosis with different types of neuropathy requiring different methods of treatment. Up to 30% of survivors of cancer may suffer from chronic pain, primarily in the form of neuropathy. Practice guidelines for workup and treatment of neuropathy in cancer patients remain inadequate.
There is no structured diagnostic or therapeutic approach or definitive guidelines for malignancy related polyneuropathy. Novel etiologies such as autoantibodies, and therapeutic modalities continue to evolve. Such advances create a gap in current pratice and guidelines.
Target Audience
All physicians.
Learning Objectives
- Demonstrate a diagnostic approach to manage malignancy related or autoimmune polyneuropathy.
- Discuss a therapeutic approach to manage malignancy related or autoimmune polyneuropathy.
- Identify potential patients with malignancy related or autoimmune polyneuropathy for neurology referral.
Additional Information
| Attachment | Size |
|---|---|
 AB 1195 & AB 241 BIBLIO_Hadi Mohammad Khanli, MD_1.24.24 | 166.88 KB |
Virtual Meeting- Zoom
Hadi Mohammad Khanli, MD Assistant Professor of Neurology, Department of Medicine, Neurology Division, City of Hope
Presenter: Dr. Khanli has indicated that there are no relevant financial relationships.
Planner: Neal Prakash, MD has indicated that there are no relevant financial relationships.
This presentation and/or comments will provide a balanced, non-promotional, and evidence-based approach to all diagnostic, therapeutic and/or research related content.
CME Committee/Reviewer no relevant financial relationships: Daneng Li, MD
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Available Credit
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2024 Department of Medicine Grand Rounds | An Overview of Autoimmune and Paraproteinemia Related Neuropathies for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance